Ms Ruby Lawlor:

The things that would be more available to people would be the drugs that have the least amount of risk associated with them, such as cannabis, MDMA or psilocybin, but the risk is also linked to the policy surrounding how someone uses a drug. It is hard to separate the two - what is the harm of the policy and the lack of services, etc., and what is the harm of the drug itself. I would say that there would be more available options in terms of less risky drugs and those that are considered more risky would be a little less available. That is hard to determine. Perhaps Professor Stevens and Ms Eastwood have a better response to that.